BetterLife Pharma BETRF Stock
BetterLife Pharma Price Chart
BetterLife Pharma BETRF Financial and Trading Overview
| BetterLife Pharma stock price | 0.07 USD |
| Previous Close | 0.06 USD |
| Open | 0.05 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.05 - 0.06 USD |
| 52 Week Range | 0.03 - 0.19 USD |
| Volume | 9.51K USD |
| Avg. Volume | 26.86K USD |
| Market Cap | 6.52M USD |
| Beta (5Y Monthly) | 1.422887 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BETRF Valuation Measures
| Enterprise Value | 9.3M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.006 |
Trading Information
BetterLife Pharma Stock Price History
| Beta (5Y Monthly) | 1.422887 |
| 52-Week Change | -16.41% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.19 USD |
| 52 Week Low | 0.03 USD |
| 50-Day Moving Average | 0.06 USD |
| 200-Day Moving Average | 0.1 USD |
BETRF Share Statistics
| Avg. Volume (3 month) | 26.86K USD |
| Avg. Daily Volume (10-Days) | 24.96K USD |
| Shares Outstanding | 108.68M |
| Float | 98.42M |
| Short Ratio | N/A |
| % Held by Insiders | 8.77% |
| % Held by Institutions | 0.0040% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | January 31, 2023 |
| Most Recent Quarter (mrq) | January 31, 2023 |
| Next Fiscal Year End | January 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -936.16% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -9239006 USD |
| Net Income Avi to Common (ttm) | -9372772 USD |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 8.31K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 80K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.01 |
| Book Value Per Share (mrq) | -0.119 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1503512 USD |
| Levered Free Cash Flow (ttm) | 2.24M USD |
Profile of BetterLife Pharma
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 1275 West 6th Avenue |
| ZIP | V6H 1A6 |
| Phone | 604-221-0595 |
| Website | https://www.abetterlifepharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders. It is also developing MM-003, which has completed Phase II clinical trials for treatment of COVID-19 and other respiratory viral infections; and MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia that has completed Phase II clinical trials. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.
Q&A For BetterLife Pharma Stock
What is a current BETRF stock price?
BetterLife Pharma BETRF stock price today per share is 0.07 USD.
How to purchase BetterLife Pharma stock?
You can buy BETRF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BetterLife Pharma?
The stock symbol or ticker of BetterLife Pharma is BETRF.
Which industry does the BetterLife Pharma company belong to?
The BetterLife Pharma industry is Biotechnology.
How many shares does BetterLife Pharma have in circulation?
The max supply of BetterLife Pharma shares is 116.39M.
What is BetterLife Pharma Price to Earnings Ratio (PE Ratio)?
BetterLife Pharma PE Ratio is now.
What was BetterLife Pharma earnings per share over the trailing 12 months (TTM)?
BetterLife Pharma EPS is -0.01 USD over the trailing 12 months.
Which sector does the BetterLife Pharma company belong to?
The BetterLife Pharma sector is Healthcare.